
瞳仁科技是一家专注于人工智能myopia prevention and control医疗方案的服务商。
Company Overview
Background and Date of Establishment: Pupil Technology was founded in 2022, the exact month may vary depending on the subsidiary or place of incorporation. The company has rapidly emerged in the field of myopia prevention and control with its unique technological advantages and market insights.
Registered capital and shareholding structureThe registered capital of Jiangsu Pupil Technology Co., Ltd. is 10,416,700 yuan, and the major shareholder is Zhejiang Ouolangvision Technology Co., Ltd. with 48% shares, while Zhejiang Ouolangvision Technology Co., Ltd. is held by Su Zhenyu with 40% shares. such a shareholding structure provides stable financial support and strategic guidance for the development of the company.
Legal representatives and key personnelLtd. is legally represented by Su Zhenyu, who has extensive experience and deep expertise in the field of myopia prevention and control. In addition, the company has a core team of industry experts and senior technicians, which provides a strong talent guarantee for the company's development.
Financing
Pupil Technology has recently completed a 10 million dollar angel round of financing, which was invested by Suzhou Jiahong Medical Fund. The funds received will be used to support further product development and production. This round of financing not only reflects the capital market's recognition of Pupil Technology's technical strength and market prospects, but also provides strong financial support for the company's future development.
Products & Services
The core product of Pupil Technology is the "OUO AI Cloud Vision System", which is a cloud-based myopia prevention and control medical system consisting of three major parts: fully automated optometry testing medical equipment, cloud-based AI diagnostic/prediction model, and OUO AI vision trainer. The system is mainly targeted at young people aged 6 to 18, and can help prevent pseudomyopia, control the process of true myopia, and significantly reduce the subsequent expenditure on myopia correction from the root.
-
Fully automated medical devices for optometric testing: The device is capable of automatic tracking, focusing and measurement, and combined with a cloud-based diagnostic system based on more than 20 myopia prevention and control indicators such as eye axis, refraction, corneal curvature, etc., it only takes more than 10 seconds to complete an optometric examination and issue a high-precision analysis report.
-
Cloud-based AI diagnostic/predictive modelingThe system is able to predict the myopia development trend of users and provide personalized intervention plans based on the "electronic vision file" generated by IoT technology and the learning and analysis of myopia data by the cloud prediction model. Pre-test results show that the prediction accuracy exceeds 90%.
-
OUO AI Vision Trainer: The product has been iterated to the sixth generation, which helps to slow down the development of myopia and eliminate pseudomyopia by utilizing a complete set of optical system based on ciliary muscle potential training, dynamic defocus control, and dynamic foggy vision, among other designs. Its focus control precision can reach 150 nanometers, much higher than the adjustment precision of general technology.
Market layout and business model
Pupil Technology is mainly oriented to the school and C-end market. At present, the company has reached cooperation with thousands of schools on the system hardware and software procurement, but also for the C-end market at the same time laying the online and offline channels, so far laying more than 100 offline stores. In terms of customer acquisition, Pupil Technology has launched a "rental experience" model, which allows customers to rent the Ou Ou AI eye care device for one month without deposit, and then decide whether to renew the device depending on the experience and effect of use. This model helps to expand the "seed users", the formation of word of mouth effect.
future outlook
Pupil Technology plans to build a more diversified product layout around "myopia prevention and control". As parents become more aware of myopia prevention and control, this market is expected to develop into a blue ocean. In the future, Pupil Technology will continue to improve the existing products, and for youth myopia control, correction and gradually incorporate other products, such as out-of-focus glasses, OK lenses, low-concentration atropine, etc., in order to achieve the effect of "1 + 1 > 2".
In summary, with its advanced technical strength, rich product line and broad market prospect, Pupil Technology has shown strong competitiveness and development potential in the field of artificial intelligence myopia prevention and control.
data statistics
Relevant Navigation

A biotechnology company specializing in new drug discovery and providing innovative drug solutions using core technologies such as DNA-encoded compound libraries.

Healer AI
Focusing on AI + Chinese medicine and health, it is committed to providing users with a full range of health management services.

United Imaging Healthcare
A leading medical technology company focused on providing high-performance medical imaging, radiotherapy products, life science instruments and medical digitalization solutions to customers worldwide.

Huakang Medical Corporation
A high-tech enterprise specializing in medical purification systems and related services, dedicated to providing hospitals with a clean, safe and intelligent medical environment through advanced medical purification technology.

Fosun Almond Pulse
Focusing on the research, development and application of medical imaging artificial intelligence technology, we are committed to improving the efficiency and accuracy of medical imaging diagnosis.

Operation Robot
Specialized in the development and application of vascular endoluminal interventional surgical robots and intelligent medical robotics.

Lingyi Zhihui
Driven by Baidu's brain technology, the AI healthcare brand, with the vision of "Empowering Primary Healthcare with Evidence-Based AI", provides a full range of healthcare solutions such as clinical assisted decision-making, fundus image analysis, and healthcare big data, to serve the primary healthcare and help improve the quality of healthcare.

Ardenne Technologies
A technology company specializing in medical big data deep mining and AI application, providing comprehensive solutions for medical institutions.
No comments...